Items per page
Sort by

Send to:

Choose Destination

Results: 7

Cited In for PubMed (Select 17189387)


Lung cancer tumorigenicity and drug resistance are maintained through ALDH(hi)CD44(hi) tumor initiating cells.

Liu J, Xiao Z, Wong SK, Tin VP, Ho KY, Wang J, Sham MH, Wong MP.

Oncotarget. 2013 Oct;4(10):1698-1711.


Rapamycin and mTORC1 inhibition in the mouse: skin cancer prevention.

Athar M, Kopelovich L.

Cancer Prev Res (Phila). 2011 Jul;4(7):957-61. doi: 10.1158/1940-6207.CAPR-11-0266.


Vascular endothelial growth factor receptor 2-targeted chemoprevention of murine lung tumors.

Karoor V, Le M, Merrick D, Dempsey EC, Miller YE.

Cancer Prev Res (Phila). 2010 Sep;3(9):1141-7. doi: 10.1158/1940-6207.CAPR-10-0005. Epub 2010 Jul 20.


Chemoprevention of murine lung cancer by gefitinib in combination with prostacyclin synthase overexpression.

Keith RL, Karoor V, Mozer AB, Hudish TM, Le M, Miller YE.

Lung Cancer. 2010 Oct;70(1):37-42. doi: 10.1016/j.lungcan.2010.01.004. Epub 2010 Jan 29.


Chemoprevention of lung squamous cell carcinoma in mice by a mixture of Chinese herbs.

Wang Y, Zhang Z, Garbow JR, Rowland DJ, Lubet RA, Sit D, Law F, You M.

Cancer Prev Res (Phila). 2009 Jul;2(7):634-40. doi: 10.1158/1940-6207.CAPR-09-0052.


Vandetanib (ZD6474), an inhibitor of VEGFR and EGFR signalling, as a novel molecular-targeted therapy against cholangiocarcinoma.

Yoshikawa D, Ojima H, Kokubu A, Ochiya T, Kasai S, Hirohashi S, Shibata T.

Br J Cancer. 2009 Apr 21;100(8):1257-66. doi: 10.1038/sj.bjc.6604988. Epub 2009 Mar 24.


The rexinoid LG100268 and the synthetic triterpenoid CDDO-methyl amide are more potent than erlotinib for prevention of mouse lung carcinogenesis.

Liby K, Black CC, Royce DB, Williams CR, Risingsong R, Yore MM, Liu X, Honda T, Gribble GW, Lamph WW, Sporn TA, Dmitrovsky E, Sporn MB.

Mol Cancer Ther. 2008 May;7(5):1251-7. doi: 10.1158/1535-7163.MCT-08-0023.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk